These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37209374)

  • 21. Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients with Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report.
    Nan D; Abraira-Meriel C; de la Roz-Fernández S; Maestre-Orozco T; Hernandez JL; Fernandez-Ayala M
    Eur J Case Rep Intern Med; 2021; 8(10):002821. PubMed ID: 34790623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: A randomized, prospective study.
    Kerget B; Çil G; Araz Ö; Alper F; Akgün M
    Med Clin (Barc); 2023 Jun; 160(12):525-530. PubMed ID: 37055254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial.
    Bazdyrev E; Panova M; Brachs M; Smolyarchuk E; Tsygankova D; Gofman L; Abdyusheva Y; Novikov F
    J Transl Med; 2022 Nov; 20(1):506. PubMed ID: 36329513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection.
    Mylvaganam RJ; Bailey JI; Sznajder JI; Sala MA;
    Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34911696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology of Pulmonary Fibrosis in the Context of COVID-19 and Implications for Treatment: A Narrative Review.
    Tran S; Ksajikian A; Overbey J; Li P; Li Y
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. When and how important is anti-fibrotic therapy in the post-COVID-19 period?
    Kerget B; Cil G; Araz O; Alper F; Akgun M
    Bratisl Lek Listy; 2022; 123(9):653-6958. PubMed ID: 36039884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Review of Respiratory Post-Acute Sequelae of COVID-19 (PASC) and the Potential Benefits of Pulmonary Rehabilitation.
    Simon M; Simmons JE
    R I Med J (2013); 2022 Sep; 105(7):11-15. PubMed ID: 35930484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae.
    Froidure A; Mahsouli A; Liistro G; De Greef J; Belkhir L; Gérard L; Bertrand A; Koenig S; Pothen L; Yildiz H; Mwenge B; Aboubakar F; Gohy S; Pilette C; Reychler G; Coche E; Yombi JC; Ghaye B
    Respir Med; 2021 May; 181():106383. PubMed ID: 33839588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors.
    Vianello A; Guarnieri G; Braccioni F; Lococo S; Molena B; Cecchetto A; Giraudo C; Bertagna De Marchi L; Caminati M; Senna G
    Clin Chem Lab Med; 2022 Feb; 60(3):307-316. PubMed ID: 34783228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection.
    Ahmad Alhiyari M; Ata F; Islam Alghizzawi M; Bint I Bilal A; Salih Abdulhadi A; Yousaf Z
    IDCases; 2021; 23():e01041. PubMed ID: 33425682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three Cases of COVID-19 Pneumonia in Female Patients in Italy Who Had Pulmonary Fibrosis on Follow-Up Lung Computed Tomography Imaging.
    Picchi G; Mari A; Ricciardi A; Carucci AC; Sinatti G; Cosimini B; Di Norcia M; Iapadre N; Balsano C; Grimaldi A
    Am J Case Rep; 2020 Nov; 21():e926921. PubMed ID: 33219200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurological post-acute sequelae of SARS-CoV-2 infection.
    Takao M; Ohira M
    Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-COVID-19 Syndrome and the Potential Benefits of Exercise.
    Jimeno-Almazán A; Pallarés JG; Buendía-Romero Á; Martínez-Cava A; Franco-López F; Sánchez-Alcaraz Martínez BJ; Bernal-Morel E; Courel-Ibáñez J
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34067776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection.
    Chun HJ; Coutavas E; Pine AB; Lee AI; Yu VL; Shallow MK; Giovacchini CX; Mathews AM; Stephenson B; Que LG; Lee PJ; Kraft BD
    JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34111030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term dyspnea, regional ventilation distribution and peripheral lung function in COVID-19 survivors: a 1 year follow up study.
    Scaramuzzo G; Ronzoni L; Campo G; Priani P; Arena C; La Rosa R; Turrini C; Volta CA; Papi A; Spadaro S; Contoli M
    BMC Pulm Med; 2022 Nov; 22(1):408. PubMed ID: 36352423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residual lung damage following ARDS in COVID-19 ICU survivors.
    Compagnone N; Palumbo D; Cremona G; Vitali G; De Lorenzo R; Calvi MR; Del Prete A; Baiardo Redaelli M; Calamarà S; Belletti A; Steidler S; Conte C; Zangrillo A; De Cobelli F; Rovere-Querini P; ; Monti G
    Acta Anaesthesiol Scand; 2022 Feb; 66(2):223-231. PubMed ID: 34758108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The alveolar fibroproliferative response in moderate to severe COVID-19-related acute respiratory distress syndrome and 1-yr follow-up.
    Zhang S; Boers LS; de Brabander J; van den Heuvel LB; Blok SG; Kullberg RFJ; Smids-Dierdorp BS; Dekker T; Aberson HL; Meijboom LJ; Vlaar APJ; Heunks L; Nossent EJ; van der Poll T; Bos LDJ; Duitman J;
    Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L7-L18. PubMed ID: 37933449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Follow-up of patients after COVID-19 pneumonia. Pulmonary sequelae].
    Chérrez-Ojeda I; Gochicoa-Rangel L; Salles-Rojas A; Mautong H
    Rev Alerg Mex; 2020; 67(4):350-369. PubMed ID: 33631903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-COVID-19 pulmonary fibrosis: An ongoing concern.
    Alrajhi NN
    Ann Thorac Med; 2023; 18(4):173-181. PubMed ID: 38058790
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.